Aspirin administration from early pregnancy versus initiation after 11 week’s gestations, for prevention of pre-eclampsia in high-risk pregnant women.
Phase 3
- Conditions
- High Risk Pregnancy for preeclampsia.Supervision of high-risk pregnancy
- Registration Number
- IRCT20221126056611N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 200
Inclusion Criteria
The participants are pregnant women at high-risk for preeclampsia based on demographic characteristics and personal and obstetrics history, according to the ACOG and USPSTF and SMFM guidelines.
Exclusion Criteria
1)Hypersensitivity to nonsteroidal anti-inflammatory drug products
2)Asthma-rhinitis and nasal polyps
3)Sever renal or sever hepatic impairment.
4)History of gastrointestinal bleeding or active peptic ulcer disease
5)vaginal bleeding or significant hematoma on ultrasound.
6)gestational age > 16 week
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method